Advertisement

The Effect of Estrogens on Depression

  • Linda S. Kahn
  • Uriel Halbreich

Keywords

Major Depressive Disorder Edinburgh Postnatal Depression Scale Postpartum Depression Biol Psychiatry Pubertal Timing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramowitz ES, Baker AH, Fleiscler S (1982) Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139: 475–478PubMedGoogle Scholar
  2. Angold A, Costello EJ, Erkanli A, Worthman CM (1999) Pubertal changes in hormone levels and depression in girls. Psychol Med 29: 1043–53PubMedCrossRefGoogle Scholar
  3. Angold A, Costello EJ, Worthman CM (1998) Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med 28: 51–61PubMedCrossRefGoogle Scholar
  4. Angst J, Frey R, Lohmeyer R, Zerben-Rubin E (1980) Bipolar manic depressive psychoses: results of a genetic investigation. Hum Genet 55: 237–254PubMedCrossRefGoogle Scholar
  5. Appleby L, Gregoire A, Platz C (1994) Screening women for high risk postnatal depression. J Psychosom Res 38: 539–545PubMedCrossRefGoogle Scholar
  6. Archer JS (1999) Relationship between estrogen, serotonin, and depression. Menopause 6: 71–78PubMedGoogle Scholar
  7. Aylward M, Holly F, Parker RI (1974) An evaluation of clinical response to pipera-zineoestronesulphate ("Harmogen") in menopausal patients. Curr Med Res Opin: 417Google Scholar
  8. Backstrom T, Landgren S, Zetterland B (1984) Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure, variation during the menstrual cycle. In: Porter RJ, Mattson RH, Ward AAJ (eds) Advances in epileptology. Raven Press, New York, 269–277Google Scholar
  9. Birge S (1997) The role of estrogen in the treatment of Alzheimer’s disease. Neurology 48(Suppl 7): S36–S41PubMedGoogle Scholar
  10. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157: 924–930PubMedCrossRefGoogle Scholar
  11. Brayshaw ND, Brayshaw DD (1986) Thyroid hypofunction in premenstrual syndrome. N Engl J Med 315: 1486PubMedGoogle Scholar
  12. Brincat M, Studd JW, O'Dow W, Magos A, Cardozo LD, Wardle PJ (1984) Subcutaneous hormone implants for the control of climetric symptoms. Lancet: 160–168Google Scholar
  13. Brockington IF, Kelly A, Hall P (1988a) Premenstrual relapse puerperal psychosis. J Affect Disord 14: 287–292PubMedCrossRefGoogle Scholar
  14. Brockington IF, Margison FR, Schofield EM, Knight RJE (1988b) The clinical picture of the depressed form of puerperal psychosis. J Affect Disord 15: 29–37PubMedCrossRefGoogle Scholar
  15. Burvill PW (1995) Recent progress in the epidemiology of major depression. Epidemiol Rev 17: 21–31PubMedGoogle Scholar
  16. Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obset Gynaecol 4: 31–47Google Scholar
  17. Campbell S (1976) Double blind psychometric studies on the effects of natural estrogens on post-menopausal women. In: Campbell S (ed) The management of menopause and postmenopausal years. MTP, Lancaster, 149–158Google Scholar
  18. Carothers AD, Murray L (1990) Estimating psychiatric morbidity by logistic regression: application to post-natal depression in a community sample. Psychol Med 20: 695–702PubMedGoogle Scholar
  19. Casper RF, Patel-Christopher A, Powell A (1989) Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab 68: 608–612PubMedGoogle Scholar
  20. Chakravorty SG, Halbreich U (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33: 229–233PubMedGoogle Scholar
  21. Coope I (1981) Is oestrogen therapy effective in the treatment of menopausal depression. J R Coll Gen Pract 31: 134–140PubMedGoogle Scholar
  22. Coope I (1981) The menopause. Is oestrogen therapy affective in the treatment of postmenopausal depression. J R Coll Gen Pract 31: 134–140PubMedGoogle Scholar
  23. Coope J, J.M. T, Poller L (1975) Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. BMJ 4: 139–143PubMedCrossRefGoogle Scholar
  24. Cooper PJ, Murray L, Hooper R, West A (1996) The development and validation of a predictive index for postpartum depression. Psychol Med 26: 627–634PubMedGoogle Scholar
  25. Coppen A, Bishop M, Beard RJ (1977) Effects on piperazine oestrone sulphate on plasma tryptophan, oestrogens, gonadotrophins and psychological functioning in women following hysterectomy. Curr Med Res Opin 4: 29–36Google Scholar
  26. Cox JL, Connor Y, Kendell RE (1982) Prospective sudy of the psychiatric disorders of childbirth. Br J Psychiatry 140: 111–117PubMedGoogle Scholar
  27. Dahr V, Murphy BEP (1990) Double-blind randomized crossover trial of luteal phase estrogens (Premarin®). Psychoneuroendrocrinology 15: 489–493Google Scholar
  28. Dalton K (1964) The premenstrual syndrome. Heinemann, LondonGoogle Scholar
  29. Demyttenaere K, Lenaerts H, Nijs P, Van Assche FA (1995) Individual coping style and psychological attitudes during pregnancy predict depression levels during pregnancy and during postpartum. Acta Psychiatr Scand 91: 95–102PubMedGoogle Scholar
  30. Dennerstein L, Burrows GD (1979) Affect and the menstrual cycle. J Affect Disord 1: 77–92PubMedCrossRefGoogle Scholar
  31. Derman RJ, Dawood MY, Stone S (1995) Quality of life during sequential hormone replacement therapy — a placebo-controlled study. Int J Fertil Menopausal Stud 40: 73–78PubMedGoogle Scholar
  32. Dickinson SL, Curzon G (1986) 5-Hydroxytryptamine-mediated behavior in male and female rats. Neuropharmacology 25: 771–776PubMedCrossRefGoogle Scholar
  33. Ditkoff EC, Crary WG, Cristo M, Lobo R (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991–995PubMedGoogle Scholar
  34. d'Orban PT, Dalton J (1980) Violent crime and the menstrual cycle. Psychol Med 10: 353–359PubMedCrossRefGoogle Scholar
  35. Endicott J, Halbreich U (1988) Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry 49: 486–489PubMedGoogle Scholar
  36. Epperson CN, Wisner KL, Yamamoto B (1999) Gonadal steroids in the treatment of mood disorders. Psychosom Med 61: 676–697PubMedGoogle Scholar
  37. Fedor-Freybergh (1977) The influence on oestrogen on wellbeing and mental performance in climacteric postmenopausal women. Acta Obstet Gynecol Scand 64: 2–10Google Scholar
  38. Frank R (1931) The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 26: 1053–1057Google Scholar
  39. Freeman E, Rickels K, Sondheimer SJ, Polansky M (1990) Ineffectiveness of progesterone suppository treatment for premenstrual syndrome: a placebo-controlled, randomized, double-blind study. JAMA 264: 349–353PubMedCrossRefGoogle Scholar
  40. Freeman EW, Sondheimer SJ, Rickels K, Weinbaum PJ (1985) PMS treatment approaches and progesterone therapy. Psychosomatics 26: 811–816PubMedGoogle Scholar
  41. Friedman RC, Hurt SW, Charkin J (1982) Sexual histories and premenstrual affective syndrome in psychiatric inpatients. Am J Psychiatry 139: 1484–1486PubMedGoogle Scholar
  42. Furuhjelm M, Karlgren E, Carlstrom K (1984) The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 63: 655–661PubMedGoogle Scholar
  43. Garlow SJ, Musselman DJ, Nemeroff CB (1999) The neurochemistry of mood disorders: clinical studies. In: Charney DS, Nestler EJ, Bunney BS (eds) Neurobiology of mental illness. Oxford University Press, New YorkGoogle Scholar
  44. George GCW, Utian WH, Beumont PJV, Bearwood CJ (1973) Effect of exogenous oestrogens on mionor psychiatric symptoms in postmenopausal women. S Afr Med J 47: 2387–2388PubMedGoogle Scholar
  45. Gerdes LC, Sonnendecker EWW, Polakow ES (1979) Psychological changes effected by estrogen-progestogen and chlonidine treatment in climacteric women. Am J Obstet Gynecol 1: 77–92Google Scholar
  46. Gladis MM, Walsh BT (1987) Premenstrual exacerbation of binge eating in bulimia. Psychiatry 144: 1592–1595Google Scholar
  47. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347: 930–3PubMedCrossRefGoogle Scholar
  48. Gurguis GN, Yonkers KA, Blakeley JE, Phan SP, Williams A, Rush AJ (1998a) Adrenergic receptors in premenstrual dysphoric disorder. II. Neutrophil beta2-adrenergic receptors: Gs protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res 79: 31–42PubMedCrossRefGoogle Scholar
  49. Gurguis GN, Yonkers KA, Phan SP, Blakeley JE, Williams A, Rush AJ (1998b) Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol Psychiatry 44: 600–609PubMedCrossRefGoogle Scholar
  50. Halbreich U, Alt IH, Paul L (1988) Premenstrual changes. Impaired hormonal homeostasis. Neurol Clin 6: 173–94PubMedGoogle Scholar
  51. Halbreich U, Ben-David M, Assael M, Bornstein R (1976) Serum-prolactin in women with premenstrual syndrome. Lancet 02: 654–656Google Scholar
  52. Halbreich U, Carson S, Rojansky N, Lane J, Alt E (1988) 20% of women who reported premenstrual dysphoric changes might have subclinical hypothyroidism. Proc Annual Meeting of the American College of Neuropsychopharmacology (ACNP). San Juan, PRGoogle Scholar
  53. Halbreich U, Endicott J, Goldstein S, Nee J (1986) Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74: 576–586PubMedGoogle Scholar
  54. Halbreich U, Endicott J, Schacht S, Nee J (1982) The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatr Scand 65: 46–65PubMedGoogle Scholar
  55. Halbreich U, Endicott J (1985) Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71: 331–338PubMedGoogle Scholar
  56. Halbreich U, Lumley LA (1993) The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J Affect Disord 29: 159–173PubMedCrossRefGoogle Scholar
  57. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N (1993) Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premen-strual syndromes. Biol Psychiatry 34: 676–686PubMedCrossRefGoogle Scholar
  58. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–441PubMedGoogle Scholar
  59. Halbreich U, Rojansky N, Palter S (1991) Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 56: 1066–1069PubMedGoogle Scholar
  60. Halbreich U, Smoller JW (1997) Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58: 399–402PubMedGoogle Scholar
  61. Halbreich U, Tworek H (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 23: 1–27PubMedGoogle Scholar
  62. Halbreich U (2000) Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry 57: 1163–1164PubMedGoogle Scholar
  63. Halbreich U (1995) Menstrually related disorders: what we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 9: 163–175PubMedGoogle Scholar
  64. Halbreich U (1997a) Menstrually related disorders — towards interdisciplinary international diagnostic criteria. Cephalalgia 17(Suppl 20): 1–4PubMedGoogle Scholar
  65. Halbreich U (1997b) Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95: 169–176PubMedGoogle Scholar
  66. Halbreich U (1996) Premenstrual Syndromes. In: Halbreich U (ed) Balliere’s clinical psychiatry: International practice and research. Bailliere Tindall, London, 667–686Google Scholar
  67. Halbreich U (1997c) Psychiatric disorders in women. In: Weller M, van Kammen D (eds) Progress in clinical psychiatry. Saunders, London, 96–115Google Scholar
  68. Halbreich U (1997d) Role of estrogen in postmenopausal depression. Neurology 48: S16–19PubMedGoogle Scholar
  69. Halbreich U (1999) RU-486, estrogen and leuprolide as treatment for PMS [abstract]. 30th Annual Meeting, ISPNE, Orlando, FloridaGoogle Scholar
  70. Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part II: Effects on selected psychotropics. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 43–71Google Scholar
  71. Hamilton JA, Yonkers KA (1996) Sex differences in pharmacokinetics of psychotropic medications: Part I: Physiological basis for effects. In: Jensvold M, Halbreich U, Hamilton JA (eds) Psychopharmacology of women: sex, gender, and hormonal considerations. American Psychiatric Press, Washington DC, 11–41Google Scholar
  72. Harrison WM, Endicott J, Nee J, Glick H, Rabkin JG (1989) Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 30: 405–411PubMedGoogle Scholar
  73. Hatotani N, Nishikubo M, Iitayama I (1979) Periodic psychosis in the female and the reproductive process. In: Zichella L, Pancheri P (eds) Psychoneuroendocrinology in reproduction. Elsevier North Holland, New York, 55–68Google Scholar
  74. Hurt SW, Schnurr PP, Severino SK, et al. (1992) Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 149: 525–530PubMedGoogle Scholar
  75. Jensvold MF, Hamilton JA (1996) Sex and gender effects in psychopharmacology: contributory factors and implications for pharmacotherapy. In: Halbreich U (ed) Psychiatric issues in women. Bailliere Tindall, London, 647–665Google Scholar
  76. Jensvold MF (1996) Nonpregnant reproductive-age women, Part I: the menstrual cycle and psychopharmacology. In: Jensvold MF, Halbreich UH, Hamilton JA (eds) Psychopharmacology and women. American Psychiatric Press, Washington DC, 139–169Google Scholar
  77. Johnson SR (1987) The epidemiology and social impact of premenstrual symptoms. Clin Obstet 30: 369–384Google Scholar
  78. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996) The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53: 391–399PubMedGoogle Scholar
  79. Kessler R (2000) Gender and mood disorders. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989–996Google Scholar
  80. Kessler RC, McGonagle KA, Zhao S, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19PubMedGoogle Scholar
  81. Kessler RC, Walters EE (1998) Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7: 3–14PubMedCrossRefGoogle Scholar
  82. Kessler RC (1995) Epidemiology of psychiatric comorbidity. In: Tsuang MT, Tohan M, Zahner GEP (eds) Textbook in psychiatric epidemiology. Wiley, New York, 179–197Google Scholar
  83. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36: 550–554PubMedGoogle Scholar
  84. Komstein SG, McEnany G (2000) Enhancing pharmacologic effects in the treatment of depression in women. J Clin Psychiatry 61(Suppl 11): 18–27Google Scholar
  85. Komstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in chronic major and double depression. J Affect Disord 60: 1–11Google Scholar
  86. Komstein SG, Schatzberg AF, Thase ME, et al. (2000) Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 157: 1445–1452Google Scholar
  87. Komstein SG, Schatzberg AF, Yonkers KA, et al. (1995) Gender differences in presentation of chronic major depression. Psychopharmacol Bull 31: 711–718Google Scholar
  88. Komstein SG (1997) Gender differences in depression: implications for treatment. J Clin Psychiatry 58(Suppl 15): 12–18Google Scholar
  89. Kouri E, Halbreich U (1998) Psychotrophic effects of hormonal replacement therapy. Drugs of Today 34: 251–257PubMedGoogle Scholar
  90. Kumar R, Robson KM (1984) A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144: 35–47PubMedCrossRefGoogle Scholar
  91. Leibenluft E, Hardin TA (1995) Gender differences in seasonal affective disorder. Depression 3: 13–19Google Scholar
  92. LeMeledo JM, Bradwein J, Koszycki D, Bichet D (1995) Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch Gen Psychiatry 52: 605–606Google Scholar
  93. Lepage P, Steiner M (1991) Gender and serotonergic deregulation: implications for late luteal phase dysphoric disorder. In: Cassano GB, Akiskal HS (eds) Serotonin related psychiatric syndromes: Clinical and therapeutic links. Roy Soc Med Service Congress Symp Series No 165, LondonGoogle Scholar
  94. Lewinsohn PM, Rohde P, Seeley JR (1998) Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 18: 765–794PubMedGoogle Scholar
  95. Luggin R, Bernsted L, Petersson B, Jacobsen AT (1984) Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand 69: 461–465PubMedGoogle Scholar
  96. Luine VN (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484–490PubMedCrossRefGoogle Scholar
  97. Magos AL, Brincat M, Studd JWW (1986) Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: Placebo controlled study. BMJ 292: 1629–1633PubMedGoogle Scholar
  98. Maoz B, Durst N (1980) The effects of oestrogen therapy on the sex life of postmenopausal women. Maturitas 2: 327–336PubMedGoogle Scholar
  99. Matsumoto A, Arai Y, Osanai M (1985) Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 2: 412–418PubMedCrossRefGoogle Scholar
  100. McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically-relevant basic sciences studies of gender differences and sex hormones effects. Psychopharmacol Bull 34: 251–259PubMedGoogle Scholar
  101. McEwen BS, Alves SE, Bulloch K (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48(Suppl 7): S8–S15PubMedGoogle Scholar
  102. McEwen BS, Woolley CS (1994) Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29: 431–436PubMedCrossRefGoogle Scholar
  103. McEwen BS (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12: 141–147PubMedCrossRefGoogle Scholar
  104. Merikangas KR, Foeldenyl M, Angst J (1993) The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243: 23–32PubMedGoogle Scholar
  105. Michael C, Kantor H, Shore H (1970) Further psychometric evaluation of older women — the effect of estrogen administration. J Gerontol 25: 337–341PubMedGoogle Scholar
  106. Montgomery JC, Appleby L, Brincat M, et al. (1987) Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1: 297–299PubMedGoogle Scholar
  107. Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Global burden of disease and injury series. The Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, Boston, 43Google Scholar
  108. Muse K, Cetel N, Futterman L, Yen SC (1984) The premenstrual syndrome: effects of ‘medical ovariectomy’. N Eng J Med 311: 1345–1349CrossRefGoogle Scholar
  109. O'Hara MW, Swain AM (1996) Rates and risk of postpartum depression — a meta-analysis. Int Rev Psychiatry 8: 37–54CrossRefGoogle Scholar
  110. O'Hara MW, Zekoski EM, Philipps LH, Wright EJ (1990) Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchild-bearing women. J Abnorm Psychol 99: 3–15PubMedCrossRefGoogle Scholar
  111. Ohayon MM, Caulet M (1995) Insomnia and psychotropic drug consumption. Progr Neuropsychopharmacol Biol Psychiatry 19: 421–431Google Scholar
  112. Ohkura T, Teshima Y, Isse K (1994) Estrogen increases cerebral and cerebellar blood flow in postmenopausal women. Menopause 2: 13–18Google Scholar
  113. Palinkas LA, Barrett-Connor E (1992) Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 80: 30–36PubMedGoogle Scholar
  114. Parry BL (1989) Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12: 207–220PubMedGoogle Scholar
  115. Paterson MEL (1982) A randomized double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climateric symptoms and biochemical parameters. Maturitas 4: 83–94PubMedCrossRefGoogle Scholar
  116. Piletz JE, Halbreich U (2000) Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry 48: 932–939PubMedGoogle Scholar
  117. Prange AJ (1972) Estrogen may well affect response to antidepressant. JAMA 219: 143–144Google Scholar
  118. Price RA, Kidd KK, Weissman MM (1987) Early onset (under age 30 years) and panic disorder as markers etiologic homogeneity in major depression. Arch Gen Psychiatry 44: 434–440PubMedGoogle Scholar
  119. Ramcharan S, Love EJ, Fick GH, Goldfien A (1992) The epidemiology of premen-strual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 45: 377–392PubMedCrossRefGoogle Scholar
  120. Rawson NSB, D'Arcy C (1991) Sedative hypnotic drug use in Canada. Health Reports 3: 33–57PubMedGoogle Scholar
  121. Reighard FT, Evans ML (1995) Use of the Edinburgh Postnatal Depression Scale in a Southern, rural population in the United States. Progr Neuropsychophamacol Biol Psychiatry 19: 1219–1224Google Scholar
  122. Rivera-Tovar AD, Frank E (1990) Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147: 1634–1636PubMedGoogle Scholar
  123. Roy A, Gang P, Cole K, Rutsky M, Reese L, Weisbord J (1993) Use of Edinburgh Postnatal Depression Scale in a North American population. Progr Neuropsy-chophamacol Biol Psychiatry 17: 501–504Google Scholar
  124. Roy-Byrne PP, Rubinow DR, Hoban MC, Grover GN, Blank D (1987) TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 144: 480PubMedGoogle Scholar
  125. Rubinow DR, Schmidt PJ, Roca CA (1998) Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 44: 839–50PubMedCrossRefGoogle Scholar
  126. Rubinow DR, Schmidt PJ, Roca CA (1998) Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. Psychopharmacol Bull 34: 289–290PubMedGoogle Scholar
  127. Saletu B, Brandstatter N, Metkam M, et al. (1995) Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with trandermal oestradiol therapy in menopasual depression. Psychophamacology 122: 321–329CrossRefGoogle Scholar
  128. Sandberg D, Endicott J, Harrison W, Nee J, Gorman J (1993) Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatr Res 46: 79–88CrossRefGoogle Scholar
  129. Schmidt PJ, Nieman L, Danaceau MA, et al. (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183: 414–420PubMedCrossRefGoogle Scholar
  130. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338: 209–216PubMedCrossRefGoogle Scholar
  131. Schmidt PJ, Roca CA, Bloch M, Rubinow DR (1997) The perimenopause and affective disorders. Semin Reprod Endocrinol 15: 91–100PubMedGoogle Scholar
  132. Schneider LS, Small G, Clary C (1998) Estrogen replacement therapy and antidepressant response to sertraline [abstract]. Annual Meeting of the American Psychiatric Association, Toronto, OntarioGoogle Scholar
  133. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 5: 97–106PubMedGoogle Scholar
  134. Schneider MA, Brotherton PL, Hailes J (1977) The effect of exogenous oestrogens on depression in menopausal women. Med J Aus 2: 162–163Google Scholar
  135. Seeman MV (2000) Mental illness in women. In: Goldman MB, Hatch MC (eds) Women and health. Academic Press, San Diego, 989–996Google Scholar
  136. Shapira B, Oppenheim G, Zohar J, Segal M, Malach D, Belmaker RH (1985) Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20: 576–579PubMedCrossRefGoogle Scholar
  137. Sherwin BB, Gelfand MM, Brender W (1985) Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47: 339–351PubMedGoogle Scholar
  138. Sherwin BB, Gelfand MM (1985) Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendoctrinology 10(3): 325–335Google Scholar
  139. Simpkins JW, Singh M, Bishop J (1994) The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer’s disease. Neurobiol Aging 15: S195–S197PubMedGoogle Scholar
  140. Singh M, Meyer EM, Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in Sprague-Dawley rats. Brain Res 644: 305–312PubMedCrossRefGoogle Scholar
  141. Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and oestradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136: 2320–2324PubMedGoogle Scholar
  142. Skegg DCG, Doll R, Perry J (1977) Use of medicines in general practice. Br Med J 1: 1561–1563PubMedCrossRefGoogle Scholar
  143. Steiner M, Born L, Marton P (2000) Menarche and mood disorders in adolescence. In: Steiner M, Yonkers K, Eriksson E (eds) Mood disorders in women. Martin Dunitz, London, 247–268Google Scholar
  144. Steiner M, Steinberg S, Stewart D, et al. (1995) Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/premenstrual dysphoria collaborative studygroup. N Eng J Med 332: 1529–1534Google Scholar
  145. Steiner M, Wheadon D, Kreider M, Bushnell W (1993) Antidepressant response to paroxetine by gender (Abstract #462). Ann Meeting American Psychiatric Association, San FranciscoGoogle Scholar
  146. Stewart DE, Boydell KM (1993) Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 23: 157–162PubMedGoogle Scholar
  147. Strickler RC, Borth R, Cecutti A, et al. (1977) The role of oestrogen replacement in the climacteric syndrome. Psychol Med 7: 631–639PubMedGoogle Scholar
  148. Studd JWW, Smith RNJ (1994) Estrogens and depression in women. Menopause 1: 3–7Google Scholar
  149. Stunkard AJ, Fernstrom MH, Price A, Frank E (1990) Direction of weight change in recurrent depression: consistency across episodes. Arch Gen Psych 47: 857–860Google Scholar
  150. Terry DJ, Mayocchi L, Hynes GJ (1996) Depressive symptomatology in new mothers: a stress and coping perspective. J Abnorm Psychol 105: 220–231PubMedCrossRefGoogle Scholar
  151. Thompson J, Oswald I (1977) Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. BMJ 19: 1317–1319Google Scholar
  152. Troutman BR, Cutrona CE (1990) Nonpsychotic postpartum depression among adolescent mothers. J Abnorm Psychol 99: 69–78PubMedCrossRefGoogle Scholar
  153. Van Valkingburg C, Akiskal HS, Puzantian V, Rosenthal T (1984) Anxious depression: clinical, family history, and naturalistic outcome — comparisons with panic and major depressive disorders. J Affect Disord 6: 67–82Google Scholar
  154. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2: 730–732PubMedGoogle Scholar
  155. Weissman MM, Bland RC, Canino GJ, et al. (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293–299PubMedGoogle Scholar
  156. Weissman MM, Klerman GL (1977) Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34: 98–111PubMedGoogle Scholar
  157. Weissman MM, Livingston BM, Leaf PJ (1991) Affective disorders. In: Robins LN, Regier DA (eds) Psychiatric disorders in America. Free Press, New YorkGoogle Scholar
  158. Weissman MM (1979) The myth of involutional melancholia. Jama 242: 742–744PubMedCrossRefGoogle Scholar
  159. West ED, Dally PJ (1992) Effect of iproniazid in depressive syndromes. BJM 1: 1491–1494Google Scholar
  160. Whiffen VE (1002) Is postpartum depression a distinct diagnosis? Clin Psychol Rev 12: 485–508Google Scholar
  161. Whiffen VE (1988) Vulnerability of postpartum depression: a prospective multivariate study. J Abnorm Psychol 97: 467–474PubMedCrossRefGoogle Scholar
  162. Wikander I, Sundblad C, Andersch B et al. (1998) Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 18: 390–398PubMedCrossRefGoogle Scholar
  163. Wiklund I, Karlberg J, Mattson L (1993) Quality of life menopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controled study. Am J Obstet Gynecol 168: 824–830PubMedGoogle Scholar
  164. Wolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12: 2549–2554Google Scholar
  165. Woods NF, Most A, Dery GK (1982) Prevalence of perimenstrual symptoms. Am J Public Health 72: 1257–1264PubMedGoogle Scholar
  166. Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T (1996) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 32: 41–46PubMedGoogle Scholar
  167. Yonkers KA, Kando JC, Cole JO, Blumenthal S (1992) Gender differences in pharma-cokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 149: 587–595PubMedGoogle Scholar
  168. Yonkers KA, Kando JC, Hamilton JA, Halbreich U (2000) Gender differences in treatment of depression and anxiety. In: Halbreich U, Montgomery SA (eds) Pharmacotherapy for mood, anxiety, and cognitive disorders. American Psychiatric Press, Washington DC, 59–74Google Scholar
  169. Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB (1998) Is the course of panic disorder the same in women and men? Am J Psychiatry 155: 596–602PubMedGoogle Scholar
  170. Yonkers KA (1998) Assessing unipolar mood disorders in women. Psychopharmacol Bull 34: 261–266PubMedGoogle Scholar
  171. Young E, Korszun A (1998) Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis. Psychiatr Clin North America 21: 309–323Google Scholar
  172. Young EA, Midgley AR, Carlson NE, Brown MB (2000) Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 57: 1157–1162PubMedGoogle Scholar
  173. Zelkowitz P, Milet TH (1995) Screening for post-partum depression in a community sample. Can J Psychiatry 40: 80–86PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • Linda S. Kahn
  • Uriel Halbreich

There are no affiliations available

Personalised recommendations